A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo
- 24 April 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (10) , D110-D114
- https://doi.org/10.1016/0002-9149(87)90064-6
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertensionJournal of Molecular Medicine, 1986
- Preliminary Experiences with HOE 498, a Novel Long-Acting Converting Enzyme Inhibitor, in Hypertensive PatientsJournal of Cardiovascular Pharmacology, 1985
- Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjectsEuropean Journal of Clinical Pharmacology, 1984
- Captopril: Evaluation of Low Doses, Twice-Daily Doses and the Addition of Diuretic for the Treatment of Mild to Moderate HypertensionClinical Science, 1982